IL6 and idiopathic pulmonary fibrosis: This is one of the few studies analyzing the usefulness of EBC in monitoring treatment response to antifibrotic agents in patients with IPF and, to our knowledge, the first study to assess IL-6, IL-8, IL-15, TNF-α and VEGF-A in EBC from patients with IPF.